Multiparametric Integrated 18F-FDG PET/MRI-Based Radiomics for Breast Cancer Phenotyping and Tumor Decoding
Lale Umutlu(Essen University Hospital), Katja Pinker(Memorial Sloan Kettering Cancer Center), Nils Martin Bruckmann(Heinrich Heine University Düsseldorf), Ken Herrmann(Klinikum rechts der Isar), Janna Morawitz(Heinrich Heine University Düsseldorf), Johannes Haubold(Institut für Medizinische Informatik, Biometrie und Epidemiologie), Christoph Rischpler(German Cancer Research Center), Gerald Antoch(Heinrich Heine University Düsseldorf), Harald H. Quick(Erwin L. Hahn Institute for Magnetic Resonance Imaging), Johannes Grueneisen(University of Duisburg-Essen), Ann‐Kathrin Bittner(University of Duisburg-Essen), Oliver Hoffmann(University of Duisburg-Essen), Marc Ingenwerth(Deutschen Konsortium für Translationale Krebsforschung), Peter Gibbs(Memorial Sloan Kettering Cancer Center), Julian Kirchner(Heinrich Heine University Düsseldorf)
Cited by 51
Related Papers
PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial
|The Lancet Oncology|2007|808
Metabolic Imaging Predicts Response, Survival, and Recurrence in Adenocarcinomas of the Esophagogastric Junction
|Journal of Clinical Oncology|2006|464
Precision Medicine and Radiogenomics in Breast Cancer: New Approaches toward Diagnosis and Treatment
|Radiology|2018|290
Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients
|Investigative Radiology|2018|276
When the Gods Were Born: Greek Cosmogonies and the Near East
|Aestimatio Sources and Studies in the History of Science|2015|275